Suravi Biotech Private Limited

Suravi Biotech Private Limited - pharma in Bhubaneswar, Orissa, India. FY 2026 financials and compliance.
CIN U24100OR2013PTC016638 Incorporated 12 March 2013 ROC Cuttack HQ Bhubaneswar, Orissa, India
Dormant Private Limited Company pharma
Data last updated
Revenue · FY 2022
-
Latest filing
EBITDA · FY 2022
*****
▲ 96.78% YoY
Net profit · FY 2022
*****
▲ 81.04% YoY
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Open charges
None
Secured borrowings
Company age
13 yrs
Est. 2013
Last financials
Mar 2024
Balance sheet date

About Suravi Biotech Private Limited

Data last updated: 28 June 2025

Suravi Biotech Private Limited is a private limited company based in Bhubaneswar, Orissa, India. The company is currently classified as dormant under Section 455 of the Companies Act - it is legally registered but has declared that it is not conducting any business operations. It specialises in pharmaceutical retail and distribution, a part of the broader pharmaceuticals sector. Incorporated on 12 March 2013, the company has been in operation for over 13 years.

Registered with ROC Cuttack under CIN U24100OR2013PTC016638.

Capital: an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Sabita Rani Patra and Gauranga Charan Patra.

Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: Plot No. 148 Sector – K3(A) Kalinga Nagar Ghatikia, Bhubaneswar, Orissa, India – 751003.

The company is classified as dormant - it is legally registered but has officially declared that it is not carrying out any business operations. A dormant company may resume operations after following the prescribed procedures.

Company Details of Suravi Biotech Private Limited
CIN U24100OR2013PTC016638
Registration Number 016638
Incorporation Date 12 March 2013
ROC Cuttack
Listing Status Unlisted
Company Status Dormant
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Key People
Gauranga Charan Patra Managing Director Sabita Rani Patra Director Ajit Kumar Sahoo Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    Plot No. 148 Sector – K3(A) Kalinga Nagar Ghatikia, Bhubaneswar, Orissa, India – 751003
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Company report
Suravi Biotech Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Suravi Biotech Private Limited report

Financials, compliance, directors, charges, ownership and filings for Suravi Biotech Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Business Activity of Suravi Biotech Private Limited

Suravi Biotech Private Limited operates primarily in the trade sector. The company has 1 registered business activity segment, reflecting its diverse operational portfolio.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
********* Trade ********* Wholesale Trading *********

Auditor Details of Suravi Biotech Private Limited

Suravi Biotech Private Limited is audited by J PRADHAN & CO for the financial year 2021. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
J PRADHAN & CO blur-value blur-value blur-value

Board of Directors of Suravi Biotech Private Limited

Suravi Biotech Private Limited is governed by 3 directors who oversee the company's operations and strategic decisions.

Current Directors
Name Designation Appointment Date Tenure Status
Sabita Rani Patra Director 12 Mar 2013 13 Years 3 Months Current
Gauranga Charan Patra Managing Director 12 Mar 2013 13 Years 3 Months Current
Ajit Kumar Sahoo
Also directs: Mitrasutra Infotech Private Limited
Director 31 Aug 2015 10 Years 10 Months Current
View all directors

Financials of Suravi Biotech Private Limited FY 2024 filings available

Suravi Biotech Private Limited reported revenue of ₹- (up ) for FY 2022. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
-
Profit
***** ▲ 81.04%
EBITDA
***** ▲ 96.78%
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Shareholding Pattern of Suravi Biotech Private Limited

As of FY 2021, Suravi Biotech Private Limited's shareholding pattern shows 100.00% by promoters. The promoters hold a majority stake, indicating strong promoter control.

2025
YEAR
38.19% Promoters
25.22% DII (Domestic Institutional)
10.28% FII (Foreign Institutional)
25.89% Public
2.42% Others
Shareholding Trend
Year 2025
Promoters 33.19%
DII 23.22%
FII 18.28%
Public 22.89%
Others 2.42%

Charges & Borrowings Suravi Biotech Private Limited

Suravi Biotech Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Suravi Biotech Private Limited

View historical data on people associated with Suravi Biotech Private Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Suravi Biotech Private Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Suravi Biotech Private Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Suravi Biotech Private Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Suravi Biotech Private Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Suravi Biotech Private Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Suravi Biotech Private Limited

MSME Payment Delays by Suravi Biotech Private Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Suravi Biotech Private Limited

Subsidiaries & Group Companies of Suravi Biotech Private Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Suravi Biotech Private Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Suravi Biotech Private Limited

MCA Filings & Documents of Suravi Biotech Private Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Suravi Biotech Private Limited

Activity
30 Sep 2024
Suravi Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Activity
31 Mar 2024
Suravi Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Cuttack.
Directors
31 Aug 2015
Ajit Kumar Sahoo was appointed as a Director on 31 Aug 2015 & has been associated with this company since 10 years 10 months.
Directors
12 Mar 2013
Sabita Rani Patra was appointed as a Director on 12 Mar 2013 & has been associated with this company since 13 years 4 months.
Directors
12 Mar 2013
Gauranga Charan Patra was appointed as a Managing Director on 12 Mar 2013 & has been associated with this company since 13 years 4 months.
Activity
12 Mar 2013
Suravi Biotech Private Limited was registered on 12 Mar 2013 with Roc Cuttack & aged 13 years 4 months as per MCA records.

Frequently Asked Questions about Suravi Biotech Private Limited

Suravi Biotech Private Limited is classified as "Dormant" under Section 455 of the Companies Act. This means the company is legally registered but has officially declared that it is not currently conducting any business operations. A dormant company can be reactivated by following the prescribed procedures with the Registrar of Companies.

Suravi Biotech Private Limited is a dormant private limited company in the pharma sector based in Bhubaneswar, Orissa, India. It was incorporated on 12 March 2013 and is registered under CIN U24100OR2013PTC016638. The company is legally registered but not currently conducting business.

The compliance status of Suravi Biotech Private Limited is compliant as of 28 June 2025.

The current directors of Suravi Biotech Private Limited are:

The CIN (Corporate Identification Number) of Suravi Biotech Private Limited is U24100OR2013PTC016638. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The primary industry of Suravi Biotech Private Limited is pharma. The company specifically operates in pharmaceutical retailers and distributors.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available